In high-risk patients, both Paxlovid, and molnupiravir were shown to reduce the chances of hospitalization or death from COVID-19, although Pfizer's was much more effective.
from Top World News- News18.com https://ift.tt/3FuEUT9
via IFTTT
from Top World News- News18.com https://ift.tt/3FuEUT9
via IFTTT
Comments
Post a Comment
dipakvparmar1979@gmail.com